España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Insulet
PODD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$276.08
0.27
0.10%
At close: -
$276.08
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Insulet (PODD) Forecast
News
Earnings
Insulet (PODD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Insulet (NASDAQ:PODD) Stock
Insulet Stock (NASDAQ: PODD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 20, 2025
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Benzinga Insights
Monday, January 13, 2025
Insulet Launches Omnipod 5 In Five More Count...
Benzinga Newsdesk
Friday, January 03, 2025
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Benzinga Insights
Insulet shares are trading higher after TD Co...
Benzinga Newsdesk
TD Cowen Maintains Buy on Insulet, Raises Pri...
Benzinga Newsdesk
Monday, December 30, 2024
Looking Into Insulet's Recent Short Interest
Benzinga Insights
Friday, December 20, 2024
Insulet shares are trading higher amid streng...
Benzinga Newsdesk
Tuesday, December 17, 2024
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
Benzinga Insights
Thursday, December 12, 2024
JP Morgan Maintains Overweight on Insulet, Ra...
Benzinga Newsdesk
Wednesday, December 11, 2024
Citigroup Maintains Buy on Insulet, Raises Pr...
Benzinga Newsdesk
Decoding 11 Analyst Evaluations For Insulet
Benzinga Insights
Wells Fargo Maintains Overweight on Insulet, ...
Benzinga Newsdesk
Monday, December 09, 2024
Canaccord Genuity Maintains Buy on Insulet, R...
Benzinga Newsdesk
Wednesday, December 04, 2024
Insulet Announces On December 3, 2024, After ...
Benzinga Newsdesk
Wednesday, November 27, 2024
Peering Into Insulet's Recent Short Interest
Benzinga Insights
Wednesday, November 20, 2024
Insulet Announces Omnipod 5 System Is Now Com...
Benzinga Newsdesk
Monday, November 11, 2024
Insulet shares are trading higher after Morga...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Insulet, R...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on Insule...
Benzinga Newsdesk
Top 4 Health Care Stocks That May Plunge This Quarter
Avi Kapoor
Friday, November 08, 2024
S&P 500 Breaks 6,000 Points, Dow Soars Above 44,000, Small Caps Eye Strongest Week In 4 Years, Tesla Hits $1 Trillion: What's Driving Markets Friday?
Piero Cingari
BTIG Maintains Buy on Insulet, Raises Price T...
Benzinga Newsdesk
Insulet shares are trading higher after the c...
Benzinga Newsdesk
Thursday, November 07, 2024
Insulet Raises FY24 Revenue Growth To Range O...
Benzinga Newsdesk
Insulet Expects Q4 Revenue Growth Of 12% To 1...
Benzinga Newsdesk
Insulet Q3 2024 Adj EPS $0.90 Beats $0.76 Est...
Benzinga Newsdesk
Wednesday, November 06, 2024
9 Analysts Have This To Say About Insulet
Benzinga Insights
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Avi Kapoor
Bernstein Initiates Coverage On Insulet with ...
Benzinga Newsdesk
Tuesday, October 29, 2024
Insulet Corporation Announced The Full Market...
Benzinga Newsdesk
Friday, October 25, 2024
'Apple Staff Tests Blood-Sugar App In Sign Of...
Benzinga Newsdesk
(PODD) - Analyzing Insulet's Short Interest
Benzinga Insights
Thursday, October 24, 2024
Here's How Much $1000 Invested In Insulet 10 Years Ago Would Be Worth Today
Benzinga Insights
Tuesday, October 15, 2024
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today
Benzinga Insights
Monday, October 14, 2024
Analyst Ratings For Insulet
Benzinga Insights
Raymond James Maintains Outperform on Insulet...
Benzinga Newsdesk
BTIG Maintains Buy on Insulet, Raises Price T...
Benzinga Newsdesk
Tuesday, October 01, 2024
Citigroup Maintains Buy on Insulet, Raises Pr...
Benzinga Newsdesk
Wednesday, September 25, 2024
Canaccord Genuity Maintains Buy on Insulet, R...
Benzinga Newsdesk
Tuesday, September 24, 2024
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Benzinga Insights
Tuesday, September 17, 2024
Analyst Expectations For Insulet's Future
Benzinga Insights
Insulet shares are trading higher after Piper...
Benzinga Newsdesk
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Piper Sandler Maintains Overweight on Insulet...
Benzinga Newsdesk
Friday, September 13, 2024
Jessica Hopfield At Insulet Decides to Exercises Options Worth $1.53M
Benzinga Insights
Thursday, September 12, 2024
Upstart, Insulet And 2 Other Stocks Executives Are Selling
Avi Kapoor
Tuesday, September 10, 2024
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
Benzinga Insights
Wednesday, September 04, 2024
Should You Continue to Retain PODD Stock in Your Portfolio Now?
Zacks
Insider Selling: Prem Singh Unloads $368K Of Insulet Stock
Benzinga Insights
Monday, September 02, 2024
Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
Lekha Gupta
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
